Skip to main content

Table 1 Demographic data and clinical characteristics of controls and ACLF patients

From: Association between plasma level of superoxide dismutase and survival of patients with acute-on-chronic liver failure

Variables Healthy control (n = 30) Cirrhosis (n = 30) ALF (n = 30) ACLF (n = 124)
Age (yr) 42.54 ± 8.65 45.68 ± 5.39 45.23 ± 9.32 47.52 ± 11.88
Sex(M/F) 24/6 24/6 24/6 103/21
PT (%) 84.58 ± 15.77 76.36 ± 16.87 45.12 ± 11.27 37.76 ± 14.54*#
Fb (g/L) 2.68 ± 0.67 2.23 ± 0.95 1.65 ± 0.51 1.56 ± 0.71*#
INR 1.21 ± 0.19 1.37 ± 0.21 2.12 ± 0.34 2.09 ± 0.69*#
WBC(1 × 109/L) 5.68 ± 1.54 4.85 ± 1.75 15.56 ± 6.45 14.46 ± 8.47*#
PLT (1 × 109/L) 225.97 ± 38.54 115.04 ± 58.21 130.21 ± 21.35 99.90 ± 61.41*#
ALT (U/L) 25.21 ± 12.31 25.81 ± 12.32 355.75 ± 301.25 288.69 ± 396.73*#
GLU (mM) 4.39 ± 0.68 4.54 ± 0.98 5.23 ± 2.56 5.83 ± 3.32*#
TBIL (μM) 13.22 ± 3.79 19.88 ± 7.98 299.32 ± 178.23 320.62 ± 136.81*#
CHOL (mM) 3.97 ± 0.69 3.45 ± 0.91 2.78 ± 0.56 2.58 ± 0.90*#
CREA (μM) 49.67 ± 11.21 57.61 ± 9.81 65.23 ± 16.56 66.09 ± 22.22*#
MELD    25.05 ± 4.89 25.16 ± 4.33
  1. ALT, alanine aminotransferase; CHOL, cholesterol; CREA, creatinine; Fb, fibrinogen; GLU, glucose; INR, international normalized ratio; PLT, platelet count; PT, prothrombin activity; TBIL, total bilirubin; WBC, white blood cell count
  2. *Compared with healthy control P < 0.05
  3. #Compared with cirrhosis P < 0.05